Prevalence and Molecular Biological Feature of Human Aberrant Crypt Foci
Prevalence and Molecular Biological Feature of Human Aberrant Crypt Foci
批准号:
12671255
负责人:
TOGASHI Kazutomo
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Purpose : To study the nature of human aberrant crypt foci (ACF). Methods: Lower part of rectums in 166 patients who gave informed consent were observed by magnifying chromo-colonoscopy for identifying and counting ACF. 125 biopsy specimens proved to be histologically ACF and were analyzed the sequence of K-ras, exon 1 by using nested PCR and direct sequencing. The sequences of K-ras in 52 hyperplastic polyps were analyzed as a comparison. Results : Median number of ACF counted in patients who had undergone colorectal cancer (CRC) surgery or who had CRC at the time of colonoscopy was the same as that in patients without CRC. Median number of ACF had no significant difference regarding gender, but that of ACF in patients with the age of 70-year or older was greater than that in younger patients (4 versus 2, p<0.0001,). Histologic diagnoses of 125 biopsy specimens were dysplastic ACF in 11, hyperplastic ACF in 26 and non-hyperplastic ACF in 88. Dysplastic ACF can be clearly discriminated from the other histologic types of ACFs, but there were a small number of intermediate type ACFs between hyperplastic ACF and non-hyperplastic ACF.K-ras mutation rates are shown in the table. K-ras mutation rate in hyperplastic ACF is similar to that in hyperplastic polyp. Non-hyperplastic ACF as well as dysplastic ACF showed higher mutation rate than hyperplastic ACF, but K-ras mutantation type was different between non-hyperplastic ACF and dysplastic ACF. Conclusions: Hyperplastic ACF can be regarded as a precursor of hyperplastic polyp. Analysis of K-ras mutant type may suggest that non-hyperplastic ACF and hyperplastic ACF are different from dysplastic ACF.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Togashi K: "Human ACF Identified by magnifying colonoscopy"Gastroenterology. 118:A. 284-284 (2000)
Togashi K:“通过放大结肠镜检查识别人类 ACF”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazutomo Togashi, Fumio Konishi, Kazuhisa Shito, Toshihiko Tsukamoto, Hideo Nagai.: "Human ACF Identified by magnifying colonoscopy"Gastroenterology. 118. A284 (2000)
Kazutomo Togashi、Fumio Konishi、Kazuhisa Shito、Toshihiko Tsukamoto、Hideo Nagai.:“通过放大结肠镜检查识别人类 ACF”胃肠病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Genetic alteration of small adenomas prospectively observed after colorectal cancer surgery.
-
批准号:17591434
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.32万
-
财政年份:2005
-
负责人:TOGASHI Kazutomo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
靶向难成药靶点K-Ras(G12D)共价抑制剂的设计与发现研究
-
批准号:22377033
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:谭毅
-
依托单位:
线粒体靶向性磁控纳米结构对K-Ras突变型肺癌细胞铁代谢的调控机制与方法研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张那明
-
依托单位:
单分子双色探针用于脂微区动态可视化及脂微区与K-Ras蛋白相互作用机理研究
-
批准号:22107028
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:豆伟涛
-
依托单位:
DCLK1与K-Ras/MAPKs通路相互作用推动胰腺癌发生发展的机制研究
-
批准号:81802738
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:葛洋
-
依托单位:
USP16调控p38 MAPK信号促K-Ras驱动肺肿瘤发生的研究
-
批准号:81802746
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:许桂琴
-
依托单位:
PI3Kα/钙调蛋白协调调控K-Ras4B在胰腺导管腺癌中的分子机制及靶点识别
-
批准号:21778037
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2017
-
负责人:陆绍永
-
依托单位:
K-Ras(G12C)抑制剂/药物共载的还原敏感性多肽纳米粒子及其抗肿瘤效应的协同作用研究
-
批准号:51573113
-
项目类别:面上项目
-
资助金额:63.0万元
-
批准年份:2015
-
负责人:樊渝江
-
依托单位:
K-RAS驱动的Lin28B/let-7通路维持PCSCs自我更新及其机制
-
批准号:81472333
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:张尤历
-
依托单位:
PD-L2介导的K-Ras突变型结直肠癌免疫逃逸及其调控机制研究
-
批准号:81471551
-
项目类别:面上项目
-
资助金额:85.0万元
-
批准年份:2014
-
负责人:王玉芳
-
依托单位:
Gd/Mn配合物修饰的鸟嘌呤核苷酸分子对K-Ras蛋白的活性调节及影像分析
-
批准号:21401045
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:孔继川
-
依托单位: